IPOs

Surface Oncology Banks $119.5 Million With IPO and Private Placement
Surface Oncology Banks $119.5 Million With IPO and Private Placement
CP Wire
Surface Oncology
IPOs
Flag link:
In knockout IPO offerings, MorphoSys and Surface Oncology haul combined $316M in upsized deals
In knockout IPO offerings, MorphoSys and Surface Oncology haul combined $316M in upsized deals
Endpoints
IPOs
MorphoSys
Surface Oncology
NASDAQ
Flag link:
Inspire Medical plans $86m IPO
Inspire Medical plans $86m IPO
Mass Device
Inspire Medical
Medtronic
obstructive sleep apnea
IPOs
devices
Flag link:
Leap of faith? Buzzy anti-aging biotech Unity pitches an $85M IPO based on mouse data
Leap of faith? Buzzy anti-aging biotech Unity pitches an $85M IPO based on mouse data
Endpoints
Unity Biotechnology
IPOs
Flag link:
Unity Biotech Files IPO to Bring Anti-Aging Drugs into Clinical Trials
Unity Biotech Files IPO to Bring Anti-Aging Drugs into Clinical Trials
Xconomy
Unity Biotechnology
IPOs
osteoarthritis
Flag link:
Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies
Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies
Xconomy
Unum Therapeutics
cell therapy
IPOs
Flag link:
No Data Yet, But Homology Upsizes IPO and Raises $144M
No Data Yet, But Homology Upsizes IPO and Raises $144M
Xconomy
Homology Med
IPOs
gene editing
Flag link:
Alzheon Files for IPO to Fund Studies of Amyloid Alzheimer’s Drug
Alzheon Files for IPO to Fund Studies of Amyloid Alzheimer’s Drug
Xconomy
Alzheon
Alzheimer's disease
IPOs
ALZ-801
Flag link:
Unum plays its first glimpse of human data in an $86M IPO, revealing two deaths and an FDA hold
Unum plays its first glimpse of human data in an $86M IPO, revealing two deaths and an FDA hold
Endpoints
Unum
IPOs
cell therapy
FDA
Flag link:
Grey Hair In the C-Suite: Experience, Age, And IPOs In Biotech
Grey Hair In the C-Suite: Experience, Age, And IPOs In Biotech
Forbes
biotech
executives
age
IPOs
Flag link:
Genprex Launch IPO For Trials Of New Gene Therapy Lung Cancer Treatment
Genprex Launch IPO For Trials Of New Gene Therapy Lung Cancer Treatment
Forbes
Genprex
IPOs
gene therapy
lung cancer
Flag link:
Nasdaq Exec 'Even More Bullish' On Biotech IPOs As New Entries Soar
Nasdaq Exec 'Even More Bullish' On Biotech IPOs As New Entries Soar
Forbes
biotech
NASDAQ
IPOs
ARMO BioSciences
Menlo Therapeutics
Cue Biopharma
Flag link:
Dermapharm targets $1bn IPO before end of quarter
Dermapharm targets $1bn IPO before end of quarter
GoinPharma
Dermapharm
IPOs
Flag link:
Boasting a late-stage Botox me-too, Evolus files for $75M IPO
Boasting a late-stage Botox me-too, Evolus files for $75M IPO
Endpoints
Evolus
Botox
Allergan
IPOs
DWP-450
biosimilars
Flag link:
A Biotech VC's Outlook For 2018
A Biotech VC's Outlook For 2018
Forbes
biotech
venture capital
venture
M&A
IPOs
Flag link:
In an end-of-year IPO blitz, 4 biotechs pitch new offerings totaling $370M
In an end-of-year IPO blitz, 4 biotechs pitch new offerings totaling $370M
Endpoints
biotech
IPOs
PureTech
ARMO BioSciences
Menlo Therapeutics
Solid Biosciences
Flag link:
Biotech IPOs show no signs of slowing down in 2018
Biotech IPOs show no signs of slowing down in 2018
BioPharma Dive
biotech
IPOs
Denali
Flag link:
Denali pulls off 2017’s biggest biotech IPO, pocketing $250M for Parkinson’s, Alzheimer’s trials
Denali pulls off 2017’s biggest biotech IPO, pocketing $250M for Parkinson’s, Alzheimer’s trials
Fierce Biotech
Denali
IPOs
Alzheimer's disease
Parkinson's Disease
Flag link:
IPO to Fuel Denali’s Drugs for Alzheimer’s, Other Brain Diseases
IPO to Fuel Denali’s Drugs for Alzheimer’s, Other Brain Diseases
Xconomy
Denali Therapeutics
IPOs
Alzheimer's disease
Flag link:
The Biotech IPO Boom Will Continue, Nasdaq Execs Predict
The Biotech IPO Boom Will Continue, Nasdaq Execs Predict
Forbes
biotech
IPOs
NASDAQ
Flag link:

Pages